Icon

CONSENSI (nda210045)- (EQ 2.5MG BASE;200MG,EQ 5MG BASE;200MG,EQ 10MG BASE;200MG)

AMLODIPINE BESYLATE; CELECOXIB PURPLE BIOTECH
EQ 2.5MG BASE;200MG,EQ 5MG BASE;200MG,EQ 10MG BASE;200MG
Yes Yes
2038-Jun-14 Expired
None None
None No
CONSENSI is a combination of amlodipine besylate, a calcium channel blocker, and celecoxib, a nonsteroidal anti-inflammatory drug (NSAID), indicated for patients for whom treatment with amlodipine for hypertension and celecoxib for osteoarthritis are appropriate. Lowering blood pressure reduces the risk of fatal and nonfatal CV events, primarily strokes and myocardial infarctions.
0 0 0
Total Other Developers 1
Drugs with Suitability No
EQ 2.5MG BASE;200MG ** ** - - -
EQ 5MG BASE;200MG ** ** - - -
EQ 10MG BASE;200MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.